Simplifying Global Compliance
FDA Committee Votes in Favor of Glaucoma Drug’s Efficacy
Clinical Trials Advisor
An FDA advisory committee voted 10-0 in favor of the efficacy of a drug candidate for treatment of glaucoma and ocular hypertension based on data from efficacy trials.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing